M.M.NaheedM.M., B.B.GreenB.B., Focus on clozapine, „Current Medical Research and Opinion”, 17 (3), 2001, s. 223–229, DOI: 10.1185/0300799039117069, PMID: 11900316(ang.).
YingY.WuYingY. i inni, Evidence that clozapine directly interacts on the GABAB receptor, „NeuroReport”, 22 (13), 2011, s. 637–641, DOI: 10.1097/WNR.0b013e328349739b, PMID: 21753741(ang.).
Stevin H.S.H.ZornStevin H.S.H. i inni, Clozapine is a potent and selective muscarinic M4 receptor agonist, „European Journal of Pharmacology”, 269 (3), 1994, s. R1–R2, DOI: 10.1016/0922-4106(94)90047-7, PMID: 7895765(ang.).
LianaL.UrichukLianaL. i inni, Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions, „Current Drug Metabolism”, 9 (5), 2008, s. 410–418, DOI: 10.2174/138920008784746373, PMID: 18537577(ang.).
KristianK.WahlbeckKristianK., Maxim V.M.V.CheineMaxim V.M.V., AdibA.EssaliAdibA., Clozapine versus typical neuroleptic medication for schizophrenia, „Cochrane Database of Systematic Reviews”, 2, 2000, s. CD000059, DOI: 10.1002/14651858.CD000059, PMID: 10796289(ang.).
Herbert Y.H.Y.MeltzerHerbert Y.H.Y., Treatment-resistant schizophrenia-the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI: 10.1185/03007999709113338, PMID: 9524789(ang.).
Andreas A.B.A.A.B.JoosAndreas A.B.A.A.B., Udo G.U.G.FrankUdo G.U.G., Wolfgang P.W.P.KaschkaWolfgang P.W.P., Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 83–85, DOI: 10.1097/00004714-199802000-00015, PMID: 9472849(ang.).
C.W.C.W.JacksonC.W.C.W., J.S.J.S.MarkowitzJ.S.J.S., T.D.T.D.BrewertonT.D.T.D., Delirium associated with clozapine and benzodiazepine combinations, „Annals of Clinical Psychiatry”, 7 (3), 1995, s. 139–141, DOI: 10.3109/10401239509149041, PMID: 8646274(ang.).
M.M.NaheedM.M., B.B.GreenB.B., Focus on clozapine, „Current Medical Research and Opinion”, 17 (3), 2001, s. 223–229, DOI: 10.1185/0300799039117069, PMID: 11900316(ang.).
YingY.WuYingY. i inni, Evidence that clozapine directly interacts on the GABAB receptor, „NeuroReport”, 22 (13), 2011, s. 637–641, DOI: 10.1097/WNR.0b013e328349739b, PMID: 21753741(ang.).
Stevin H.S.H.ZornStevin H.S.H. i inni, Clozapine is a potent and selective muscarinic M4 receptor agonist, „European Journal of Pharmacology”, 269 (3), 1994, s. R1–R2, DOI: 10.1016/0922-4106(94)90047-7, PMID: 7895765(ang.).
LianaL.UrichukLianaL. i inni, Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions, „Current Drug Metabolism”, 9 (5), 2008, s. 410–418, DOI: 10.2174/138920008784746373, PMID: 18537577(ang.).
KristianK.WahlbeckKristianK., Maxim V.M.V.CheineMaxim V.M.V., AdibA.EssaliAdibA., Clozapine versus typical neuroleptic medication for schizophrenia, „Cochrane Database of Systematic Reviews”, 2, 2000, s. CD000059, DOI: 10.1002/14651858.CD000059, PMID: 10796289(ang.).
Herbert Y.H.Y.MeltzerHerbert Y.H.Y., Treatment-resistant schizophrenia-the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI: 10.1185/03007999709113338, PMID: 9524789(ang.).
Andreas A.B.A.A.B.JoosAndreas A.B.A.A.B., Udo G.U.G.FrankUdo G.U.G., Wolfgang P.W.P.KaschkaWolfgang P.W.P., Pharmacokinetic interaction of clozapine and rifampicin in a forensic patient with an atypical mycobacterial infection, „Journal of Clinical Psychopharmacology”, 18 (1), 1998, s. 83–85, DOI: 10.1097/00004714-199802000-00015, PMID: 9472849(ang.).
C.W.C.W.JacksonC.W.C.W., J.S.J.S.MarkowitzJ.S.J.S., T.D.T.D.BrewertonT.D.T.D., Delirium associated with clozapine and benzodiazepine combinations, „Annals of Clinical Psychiatry”, 7 (3), 1995, s. 139–141, DOI: 10.3109/10401239509149041, PMID: 8646274(ang.).